Killian Meara

Articles

Lenacapavir Approved for Twice-Yearly Injection for HIV Prevention, a Landmark FDA Decision

June 19, 2025

The only pre-exposure prophylaxis approved for twice-a-year dosing, lenacapavir "could be the transformative PrEP option we’ve been waiting for," one expert said.

First-Ever MDMA-Assisted Therapy for PTSD is Granted FDA Priority Review

February 13, 2024

If the FDA approves the treatment, it will be the first-ever MDMA-assisted therapy and psychedelic-assisted therapy. The PDUFA date is set for August 11, 2024.

Moderna mRNA RSV Vaccine for Adults Returns Positive Phase 3 Results

January 08, 2024

Moderna's investigational vaccine against RSV in adults showed mean efficacy of 83% against the infection and is the only mRNA technology-based RSV shot.

Paxlovid Associated with Virologic Rebound in One in Five Patients with Severe COVID-19 Infection

November 16, 2023

The finding implies the potential for virus transmission after initial recovery from the infection, according to study authors.